Antimicrobials for the treatment of urinary tract infection in pregnancy: Practices in southern India

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 9, 2004, Pages 645-652

  Mathai, Elizabeth ^a,b   Thomas, Raja John ^a   Chandy, Sujith ^a   Mathai, Matthews ^a   Bergstrom, Staffan ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antimicrobials; Cystitis; India; Pregnancy; Prescriptions; Pyelonephritis; Rational drug use; Urinary infection

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; ANTIINFECTIVE AGENT; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NITROFURANTOIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYSTITIS; DRUG COST; DRUG SAFETY; DRUG USE; ESCHERICHIA COLI; FEMALE; HOSPITAL CARE; HUMAN; INDIA; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PRACTICE GUIDELINE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; URINALYSIS; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS, URINARY; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS, UNIVERSITY; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; URINARY TRACT INFECTIONS;

EID: 4644221622     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.950     Document Type: Article

References (20)

1. Villar J, Lydon-Rochelle MT, Gulmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. The Cochrane Library, 2003, issue 2.
2. Vazequez JC, Villar J. Treatments of symptomatic urinary tract infections during pregnancy. The Cochrane Library, 2003, issue 2.
3. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. The Cochrane Library, 2003, issue 2.
4. Jamie WE, Edwards RK, Duff P. Antimicrobial susceptibility of gram-negative uropathogens isolated from obstetric patients. Infect Dis Obstet Gynecol 2002; 10: 123-126.
5. Krcmery S, Hromec J, Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents 2001; 17: 279-282.
6. Fluit AC, Schmitz FJ. Bacterial resistance in urinary tract infection: how to stem the tide. Expert Opin Pharmacother 2001; 2: 813-818. 7 NCCLS. Performance Standards for Antimicrobial Disk Susceptibility Testing. Wayne: Pennsylvania USA, 2002; M100.
7. NCCLS. Performance Standards for Antimicrobial Disk Susceptibility Testing. Wayne: Pennsylvania USA, 2002; M100.
8. Lundborg CS. Information and Interaction. Influencing Drug Prescribing in Swedish Primary Care. Doctoral thesis, Karolinska Institutet: Stockholm, Sweden, 1999.
9. www.perinatology.com. Drugs in pregnancy and breast feeding. 2002.
10. Duff P. Antibiotic selection in obstetrics: making cost-effective choices. Clin Obstet Gynecol 2002; 45: 59-72.
11. Mandal P, Kapil A, Goswani K, Das B, Dwivedi SN. Uropathogenic Escherichia coli causing urinary tract infections. Indian J Med Res 2001; 114: 207-211.
12. Navaneeth BV, Belwadi S, Suganthi N. Urinary pathogens' resistance to common antibiotics: a retrospective analysis. Trop Doct 2002; 32: 20-22.
13. Ram S, Gupta R, Gaheer M. Emerging antibiotic resistance among the uropathogens. Indian J Med Sci 2000; 54: 388-394.
14. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham, D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46: 94-100.
15. Gupta K, Hooton TM, Wobbe CL, Stamm WE. The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents 1999; 11: 305-308.
16. Bonadio M, Meini M, Spitaleri P, Gigli C. Current microbiological and clinical aspects of urinary tract infections. Eur Urol 2001; 40: 439-444; discussion 445.
17. Orrett FA, Shurland SM. The changing patterns of antimicrobial susceptibility of urinary pathogens in trinidad. Singapore Med J 1998; 39: 256-259.
18. McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994; 33(Suppl. A): 23-30.
19. Sefton AM. The impact of resistance on the management of urinary tract infections. Int J Antimicrob Agents 2000; 16: 489-491.
20. Whitehead M, Dahlgren G, Evans T. Equity and health sector reforms: can low-income countries escape the medical poverty trap? Lancet 2001; 358: 833-836.